Southern Research Institute awarded five-year IDIQ contract from NCI

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

SOUTHERN RESEARCH INSTITUTE was awarded a five-year IDIQ contract with a potential value of $19 million from NCI to study the preclinical toxicology of new drugs that are under development for treatment of cancer. The toxicology contract is one of three ongoing contracts between Southern Research and the NCI, and is the latest in a...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

After reading “Breast Cancer Mortality Continues Three-Decade Decline, but Steeper Increases for Women Under 50 & AAPI Women of All Ages,” it is evident that while overall progress is being made in the fight against cancer, concerning disparities remain—particularly within the Native Hawaiian and Pacific Islander (NHPI) communities. 

Login